丹参酮IIa磺酸钠量杂质的分离及结构鉴定药学本科毕业论文.doc

Separation Of Microimpurity And Identification Of Sodium Tanshinone Ⅱa Sulfonate 丹参酮IIa磺酸钠微量杂质的分离及结构鉴定摘要参考文献致谢丹参酮IIa磺酸钠微量杂质的分离及结构鉴定： Separation of Microimpurity and Identification of Sodium Tanshinone IIa Sulfonate Abstract: Salvia miltiorrhiza is one of the most important tradition Chinese medicinal materials that possess the function of both promoting blood flow and removing blood stasis with anti-coronary artery disease. The consumed quantity only in the aspect of injection has been exceeded 2 billion dosages every year. However, because the undetermined active ingredients and relaxed index of quality control induced the instable effects of clinic traterment, and, moreover, usually adverse functions, which lead salvia miltiorrhiza unable to accommodate requirement of contemporary Chinese medicinal materials melting world. Sulfotanshinone sodium is asodium chloride of water-solubility after sulfonating tanshinone IIa of liposolubility active ingredien tabstraeted in salvia miltiorrhiza.It is an effective medicine of angiocardiopathy to treat coronary artery disease, anginacordis，and myocardial infarction.The amount of clincal utilization continuous. increasing with the high proportion of patients of angiocardiopathy induces raw material resource of salvia miltiorrhiza insufficient in China. So it becomes an extensive focus point in fharmaceutical factory that sufficient utilize and cut down uymost dissipation resource of salvia miltiorrhiza. Keywords:1-Hydroxy-Tanshinone IIa sulfonate ; sodium tanshinoneⅡA sulphonate(STS);tanshinoneIIa;separation;identification 前言 丹参是活血化淤的传统中药，具有良好的抗冠心病等作用。其制剂及复方制剂品种繁多，仅注射剂的年使用量就达20亿支以上，但多数产品有效成分不明确，质量控制指标不严格，由此导致临床疗效不稳定，不良反应时常出现，因此不能适应中药生产现代化和向国际市场挺进的要求。 丹参酮IIa磺酸钠，是从药材丹参中提取的主要脂溶性有效成分丹参酮IIa经磺化反应后形成的一种水溶性钠盐，由于磺酸基的引入，提高了丹参酮IIa的水溶性，在治疗冠心病、心绞痛、心肌梗塞等疾病方面显示出与丹参酮IIa所无法比拟的优越性，成为主要的心血管类中药[11]。由于我国心血管疾病患者在人群中比例居高不下，该药品市场需求量呈逐年增加趋势，但是因为其杂质不明确，安全问题一直是制药企业关心的问题。 目前从丹参中提取丹参酮IIa 的方法和药理活性研究较多，但对于丹参酮IIa磺酸钠杂质的研究很少